AlloDerm is a dermal implant material derived from donated human skin tissue supplied by U.S. AATB-compliant tissue banks utilizing the standards of the American Association of Tissue Banks (AATB) and Food and Drug Administration’s (FDA) guidelines.
When AlloDerm is prepared, human donor tissue undergoes a multi-step proprietary process that removes both the epidermis and any cells that can lead to tissue rejection and graft failure.
Once the dermal tissue has been decellularized, preservation is completed with a patented freeze-drying process that prevents damaging ice crystals from forming.
The cells responsible for immune response and graft rejection are removed. What remains is a framework of natural biological components, ready to enable the body to mount its own tissue regeneration process in areas where flesh is missing or damaged.